Article thumbnail

Identification of Mannich Base as a Novel Inhibitor of Mycobacterium Tuberculosis Isocitrate by High-Throughput Screening

By Lei Ji, Quanxin Long, Dacheng Yang and Jianping Xie


Mycobacterium tuberculosis (MTB) remains one of the most significant human pathogens since its discovery in 1882. An estimated 1.5 million people died from tubercle bacillus (TB) in 2006, and globally, there were an estimated 9.27 million incident cases of TB in 2007. Glyoxylate bypass pathway occurs in a wide range of pathogens and plays a key role in the pathogenesis of Mycobacterium tuberculosis. Isocitrate lyase (ICL) can catalyses the first step of this pathway, and reversibly cleaves isocitrate into succinate and glyoxylate. So, ICL may represent a good drug target for the treatment of tuberculosis. ICL was cloned, expressed, and purified, and a high-throughput screen (HTS) developed to screen active molecule from a mannich base compounds library for inhibition of ICL. This assay had signal to noise (S/N) of 650.6990 and Z' factor of 0.8141, indicating that the assay was suitable for HTS. Screening of a collection of 124 mannich base compounds resulted in the identification of one mannich base compound, which has a significant inhibitory activity. So, a new family of compound was first reported to inhibit the activity of Mycobacterium tuberculosis ICL. This family of compound might offer new avenue to explore better anti-tuberculosis and fungi drugs

Topics: Research Paper
Publisher: Ivyspring International Publisher
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2007). A class of compounds that has the Mannich base stucture and its applications in the preparation of the treatment and/or prevention of leukemia drug. Chinese patent application No.200710092667.9.
  2. (1953). A deviation from the conventional tricarboxylic acid cycle in Pseudomonas aeruginosa. Biochim Biophys Acta.
  3. (2006). A high throughput screening approach to identify isocitrate lyase inhibitors from traditional Chinese medicine sources. Drug Dev Res.
  4. (2008). A kind of new β-amino ketone/alcohol derivatives and its use. Chinese patent application No.200810148122.X.
  5. (1999). A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen.
  6. (2008). Discovery and biological characterization of a novel series of androgen receptor modulators.
  7. (1990). Further advances in the chemistry of mannich bases.
  8. (2000). In vivo veritas: the search for TB drug targets goes live. Nat Med.
  9. (2002). Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryot Cell.
  10. (1989). Molecular cloning: a laboratory manual.
  11. (2000). Molecular genetics of mycobacteria.
  12. (2000). Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
  13. present and future of TB control.
  14. (2002). Resources required for global tuberculosis control.
  15. (2000). Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat Struct Biol.
  16. (1932). Studies on plant amylases: The effect of starch concentration upon the velocity of hydrolysis by the amylase of germinated barley.
  17. (1991). Synthesis and anti-inflammatory and anticancer activities of 2-(E)- (un)substituted benzylidene cyclopentanones and their Mannich base hydro chlorides. Acta Pharm Sin.
  18. (1998). Synthesis and antiinflammatory activity of 2-substituted cyclo-pentanone or 2-cyclopentenone Mannich bases from aromatic amines. Chin J Med Chem.
  19. (2006). Synthesis and antitumor activities of 2-(E)-(4-cyclo -pentyloxy -3-methyl-benzylidene) cyclopentanone arylamine Mannich bases. Chin J Med Chem.
  20. (2000). Synthesis and biological evaluation of certain alpha,beta-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents. J Med Chem.
  21. (2005). Synthesis and in vitro study of novel Mannich bases as antibacterial agents. Bioorg Med Chem Lett.
  22. (2009). Synthesis and Preliminary Evaluation of Antidiabetic Activity of 4-(1-Aryl-3-aryl/arylalkyl-3-oxopropylamino)-N-(5-methyl-3-is oxazolyl)benzene Sulfonamide. Chin J Org Chem.
  23. (2009). Synthesis and α -glucosidase inhibitory activity of N-(1,5-diaryl-3-pentone-1-yl)-4-aminobenzoic acid. Acta Pharm Sin.
  24. (1957). Synthesis of cell constituents from C2-units by a modified tricarboxylic acid cycle.
  25. (2001). Synthesis of Mannich bases of some 2,5-disubstituted 4-thiazolidinones and evaluation of their antimicrobial activities. Arch Pharm (Weinheim).
  26. The crystal structure and active site location of isocitrate lyase from the fungus Aspergillus nidulans.
  27. The glyoxylate cycle is required for fungal virulence.
  28. β-amino ketone derivatives for antidiabetic activity. Chinese patent application No.